SARS-CoV-2,CD8+ MAITKLRD1

Xiaowen Dou1, Mian Peng2, Ruiwei Jiang1

  • 1Medical Laboratory of the Third Affiliated Hospital of Shenzhen University, Shenzhen, China.

Frontiers in immunology
|September 1, 2023
PubMed
概括

无活化的SARS-CoV-2疫苗接种增强T细胞免疫力,增强早期反应. 这项研究揭示了疫苗接种后显著的CD8+T细胞子集激活和基因表达变化.